(Q34563064)

3 August 2017

1 reference

title

Drugs affecting homocysteine metabolism: impact on cardiovascular risk (English)

1 reference

3 August 2017

1 reference

Cyrus Desouza

1

1 reference

3 August 2017

Mary Keebler

series ordinal

2

1 reference

3 August 2017

Dennis B McNamara

series ordinal

3

1 reference

3 August 2017

Vivian Fonseca

series ordinal

4

1 reference

3 August 2017

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

62

1 reference

3 August 2017

605-616

1 reference

3 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262040-00005

3 August 2017

0 references

cites work

Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia

1 reference

12 December 2020

Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.

1 reference

12 December 2020

The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine

1 reference

12 December 2020

Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis

1 reference

12 December 2020

Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat

1 reference

12 December 2020

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

1 reference

12 December 2020

Homocysteine, B vitamins, and coronary artery disease

1 reference

12 December 2020

The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial

1 reference

12 December 2020

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

1 reference

12 December 2020

The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.

1 reference

12 December 2020

Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes

1 reference

12 December 2020

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

12 December 2020

Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.

1 reference

12 December 2020

Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin

1 reference

12 December 2020

Plasma homocysteine concentrations in patients with type 1 diabetes.

1 reference

12 December 2020

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

1 reference

12 December 2020

Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study

1 reference

12 December 2020

Treatment of mild hyperhomocysteinemia in vascular disease patients

1 reference

12 December 2020

Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat.

1 reference

12 December 2020

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Plasma Homocysteine in Women Taking Hormone Replacement Therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

1 reference

12 December 2020

Depression of the Intestinal Uptake of Radio-vitamin B12 by Cholestyramine

1 reference

12 December 2020

Lipid-lowering drugs and homocysteine

1 reference

12 December 2020

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

1 reference

12 December 2020

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine

1 reference

12 December 2020

Elevated plasma concentrations of homocysteine in antiepileptic drug treatment

1 reference

12 December 2020

Affinity of cystathionine beta-synthase for pyridoxal 5'-phosphate in cultured cells. A mechanism for pyridoxine-responsive homocystinuria

1 reference

12 December 2020

Correlation between plasma homocyst(e)ine and aortic atherosclerosis.

1 reference

12 December 2020

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

1 reference

12 December 2020

Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy

1 reference

12 December 2020

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

1 reference

12 December 2020

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

12 December 2020

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

1 reference

12 December 2020

Systematic review on the risk and benefit of different cholesterol-lowering interventions

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women.

1 reference

12 December 2020

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.

1 reference

12 December 2020

Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

1 reference

12 December 2020

Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen

1 reference

12 December 2020

Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents

1 reference

12 December 2020

Homocysteine and cardiovascular disease

1 reference

12 December 2020

Efficacy of Gemfibrozil in Dyslipidaemic Subjects with Suspected Heart Disease. An Ancillary Study in the Helsinki Heart Study Frame Population

1 reference

12 December 2020

Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation.

1 reference

12 December 2020

Association between plasma homocysteine and extracranial carotid arterial disease in older persons

1 reference

12 December 2020

Abnormal homocysteine metabolism in rheumatoid arthritis

1 reference

12 December 2020

Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Homocysteine and coronary atherosclerosis

1 reference

12 December 2020

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease

1 reference

12 December 2020

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

12 December 2020

Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction.

1 reference

12 December 2020

Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.

1 reference

12 December 2020

Decreased serum homocysteine in pregnancy

1 reference

12 December 2020

The effect of supraphysiologic doses of testosterone on fasting total homocysteine levels in normal men.

1 reference

12 December 2020

Fibrates, dyslipoproteinaemia and cardiovascular disease

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

1 reference

12 December 2020

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

12 December 2020

Increased plasma homocysteine after menopause

1 reference

12 December 2020

No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.

1 reference

12 December 2020

Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects

1 reference

12 December 2020

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

1 reference

12 December 2020

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

1 reference

12 December 2020

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

12 December 2020

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

1 reference

12 December 2020

Plasma homocysteine and menopausal status.

1 reference

12 December 2020

Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants

1 reference

12 December 2020

Implication of fibrate therapy for homocysteine

1 reference

12 December 2020

10.2165/00003495-200262040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference